I kliniske forsøg hos patienter med lægemiddelinduceret (dopaminagonist) psykose i relation til Parkinsons sygdom blev forværring af Parkinson symptomatologi og hallucinationer meget almindeligt rapporteret og hyppigere end for placebo.
In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson’ s disease, worsening of Parkinsonian symptomatology and hallucinations were reported very commonly and more frequently than with placebo.